Works matching IS 03618609 AND DT 2023 AND VI 98 AND IP 11

Results: 37
    1
    2
    3
    4
    5
    6
    7
    8

    Risk of progression in chronic phase‐chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR‐PRO study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. 1762, doi. 10.1002/ajh.27073
    By:
    • Zambrotta, Giovanni Paolo Maria;
    • Nicolini, Franck E.;
    • Assouline, Sarit;
    • Busque, Lambert;
    • Pungolino, Ester;
    • Abruzzese, Elisabetta;
    • Miggiano, Maria Cristina;
    • Elena, Chiara;
    • Alvarez‐Larran, Alberto;
    • Triguero, Ana;
    • Iurlo, Alessandra;
    • Bucelli, Cristina;
    • Cerrano, Marco;
    • Capodanno, Isabella;
    • Lunghi, Francesca;
    • le Coutre, Philipp;
    • Galimberti, Sara;
    • Caocci, Giovanni;
    • Maffioli, Margherita;
    • Stagno, Fabio
    Publication type:
    Article
    9

    Immunomodulatory cytokines and clonal dynamics in low‐risk myelodysplastic syndromes patients treated with luspatercept.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. E345, doi. 10.1002/ajh.27072
    By:
    • Fattizzo, Bruno;
    • Marchetti, Alfredo;
    • Zaninoni, Anna;
    • Lionetti, Marta;
    • Riva, Marta;
    • Rizzo, Lorenzo;
    • Pettine, Loredana;
    • Galli, Nicole;
    • Mazzon, Federico;
    • Fermo, Elisa;
    • Maeda, Akihiro;
    • Marella, Alessio;
    • Da Vià, Matteo Claudio;
    • Passamonti, Francesco;
    • Bolli, Niccolò;
    • Barcellini, Wilma
    Publication type:
    Article
    10

    Ongoing symptoms following complete surgical excision in unicentric Castleman disease.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. E334, doi. 10.1002/ajh.27065
    By:
    • Sarmiento Bustamante, Mateo;
    • Shyamsundar, Saishravan;
    • Coren, Freda R.;
    • Bagg, Adam;
    • Srkalovic, Gordan;
    • Alapat, Daisy;
    • van Rhee, Frits;
    • Lim, Megan S.;
    • Lechowicz, Mary Jo;
    • Brandstadter, Joshua D.;
    • Pierson, Sheila K.;
    • Fajgenbaum, David C.
    Publication type:
    Article
    11

    Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. 1780, doi. 10.1002/ajh.27070
    By:
    • Bataller, Alex;
    • Loghavi, Sanam;
    • Gerstein, Yoheved;
    • Bazinet, Alexandre;
    • Sasaki, Koji;
    • Chien, Kelly S.;
    • Hammond, Danielle;
    • Montalban‐Bravo, Guillermo;
    • Borthakur, Gautam;
    • Short, Nicholas;
    • Issa, Ghayas C.;
    • Kadia, Tapan M.;
    • Daver, Naval;
    • Tang, Guilin;
    • Quesada, Andres;
    • Patel, Keyur P.;
    • Ravandi, Farhad;
    • Fiskus, Warren;
    • Mill, Cristopher P.;
    • Kantarjian, Hagop M.
    Publication type:
    Article
    12
    13

    Severe cutaneous necrosis in antiphospholipid syndrome.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. E328, doi. 10.1002/ajh.27067
    By:
    • Mostafa, Mariam;
    • Mahmoud, Amir;
    • Egiza, Hebat‐Allah;
    • Niu, Chengu;
    • Elbahnasawy, Mohamed;
    • Yusuf, Yasmin;
    • Kouides, Peter
    Publication type:
    Article
    14
    15
    16

    Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. 1751, doi. 10.1002/ajh.27069
    By:
    • Ong, Shin Yeu;
    • Pak, Stacy;
    • Mei, Matthew;
    • Wang, Yan;
    • Popplewell, Leslie;
    • Baird, John H.;
    • Herrera, Alex F.;
    • Shouse, Geoffrey;
    • Nikolaenko, Liana;
    • Zain, Jasmine;
    • Godfrey, James;
    • Htut, Myo;
    • Aribi, Ahmed;
    • Spielberger, Ricardo;
    • Mansour, Joshua;
    • Forman, Stephen J.;
    • Palmer, Joycelynne;
    • Budde, Lihua E.
    Publication type:
    Article
    17
    18
    19

    Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. E318, doi. 10.1002/ajh.27060
    By:
    • Kosydar, Samuel R.;
    • Parikh, Sameer A.;
    • Lester, Scott C.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Burlile, Jessica F.;
    • Kenderian, Saad S.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Call, Timothy G.;
    • Breen, William G.;
    • Hampel, Paul J.
    Publication type:
    Article
    20

    The complex relationship between iron status and anemia in pregnant and postpartum women in India: Analysis of two Indian study cohorts of uncomplicated pregnancies.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. 1721, doi. 10.1002/ajh.27059
    By:
    • Nair, Manisha;
    • Choudhury, Saswati S.;
    • Rani, Anjali;
    • Solomi, Carolin;
    • Kakoty, Swapna D.;
    • Medhi, Robin;
    • Rao, Sereesha;
    • Mahanta, Pranabika;
    • Zahir, Farzana;
    • Roy, Indrani;
    • Chhabra, Shakuntala;
    • Deka, Gitanjali;
    • Minz, Bina;
    • Deka, Rupanjali;
    • Opondo, Charles;
    • Churchill, David;
    • Lakhal‐Littleton, Samira;
    • Nemeth, Elizabeta
    Publication type:
    Article
    21
    22

    The CAR‐HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. 1699, doi. 10.1002/ajh.27056
    By:
    • Rejeski, Kai;
    • Wang, Yucai;
    • Albanyan, Omar;
    • Munoz, Javier;
    • Sesques, Pierre;
    • Iacoboni, Gloria;
    • Lopez‐Corral, Lucia;
    • Ries, Isabelle;
    • Bücklein, Veit L.;
    • Mohty, Razan;
    • Dreyling, Martin;
    • Baluch, Aliyah;
    • Shah, Bijal;
    • Locke, Frederick L.;
    • Hess, Georg;
    • Barba, Pere;
    • Bachy, Emmanuel;
    • Lin, Yi;
    • Subklewe, Marion;
    • Jain, Michael D.
    Publication type:
    Article
    23
    24
    25

    Phase II study of cladribine, idarubicin, and ara‐C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. 1711, doi. 10.1002/ajh.27054
    By:
    • Kadia, Tapan M.;
    • Ravandi, Farhad;
    • Molica, Matteo;
    • Bataller, Alex;
    • Borthakur, Gautam;
    • Daver, Naval;
    • Jabbour, Elias;
    • DiNardo, Courtney D.;
    • Pemmaraju, Naveen;
    • Jain, Nitin;
    • Ferrajoli, Alessandra;
    • Ylimaz, Musa;
    • Bose, Prithviraj;
    • Tidwell, Rebecca Slack;
    • Marx, Kayleigh R.;
    • Rausch, Caitlin R.;
    • Kanagal‐Shamanna, Rashmi;
    • Wang, Sa;
    • Islam, Rabiul;
    • Champlin, Richard
    Publication type:
    Article
    26
    27
    28
    29
    30

    Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. E305, doi. 10.1002/ajh.27053
    By:
    • van Baarle, Floor L. F.;
    • van de Weerdt, Emma K.;
    • van der Velden, Walter J. F. M.;
    • Ruiterkamp, Roelof A.;
    • Tuinman, Pieter R.;
    • Ypma, Paula F.;
    • van den Bergh, Walter M.;
    • Demandt, Astrid M. P.;
    • Kerver, Emile D.;
    • Jansen, A. J. Gerard;
    • Westerweel, Peter E.;
    • Arbous, M. Sesmu;
    • Determann, Rogier M.;
    • van Mook, Walther N. K. A.;
    • Koeman, Mirelle;
    • Mäkelburg, Anja B. U.;
    • van Lienden, Krijn P.;
    • Vlaar, Alexander P. J.;
    • Biemond, Bart J.
    Publication type:
    Article
    31
    32

    Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine—A prospective cohort study by the AGMT

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. 1685, doi. 10.1002/ajh.27046
    By:
    • Pleyer, Lisa;
    • Vaisband, Marc;
    • Drost, Manuel;
    • Pfeilstöcker, Michael;
    • Stauder, Reinhard;
    • Heibl, Sonja;
    • Sill, Heinz;
    • Girschikofsky, Michael;
    • Stampfl‐Mattersberger, Margarete;
    • Pichler, Angelika;
    • Hartmann, Bernd;
    • Petzer, Andreas;
    • Schreder, Martin;
    • Schmitt, Clemens A.;
    • Vallet, Sonia;
    • Melchardt, Thomas;
    • Zebisch, Armin;
    • Pichler, Petra;
    • Zaborsky, Nadja;
    • Machherndl‐Spandl, Sigrid
    Publication type:
    Article
    33
    34
    35

    Is this really thalassemia?

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. 1814, doi. 10.1002/ajh.26913
    By:
    • Thomas, Benoit;
    • Visanica, Sorin;
    • Poussing, Sophie;
    • Gérard, Delphine;
    • Perrin, Julien
    Publication type:
    Article
    36

    Issue Information.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. 1667, doi. 10.1002/ajh.26614
    Publication type:
    Article
    37